Company intelligence / Profile preview
Emcutix Biopharmaceuticals
Pune, Maharashtra, Indiaemcutix.fbmlive.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Emcutix offers category-defining commercial products in dermatology, including prescription, consumer, and aesthetic segments. Key launches like Ureaderm (urea-based moisturizers for psoriasis, ichthyosis, dry skin), PRX-PLUS (non-invasive skin tightening), and Flawlizo (acne care) are available across India, with evidence-based efficacy focused on skin barrier restoration and hydration[1][3][11].
- Therapeutic areas
- Dermatology
- Modalities
- Small moleculeBiologicMedical device (cosmeceutical/aesthetic)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Mantra Pharma (Ureaderm launch, manufacturing/marketing)[1]WiQo (exclusive in-license for PRX-PLUS)[3][7][8]
Beyond the preview
Go deeper on Emcutix Biopharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Emcutix Biopharmaceuticals.